Furthermore, some of these molecules like IL-1β, HDAC5 and OLR1 (LOX-1) have already been flagged as potential therapeutic targets for RA [72–74] strengthening their importance in arthropathies. This evidence concerns the gene IL1B and rheumatoid arthritis.